Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry

This publication has 21 references indexed in Scilit:

• First Characterization of AKB-48 Metabolism, a Novel Synthetic Cannabinoid, Using Human Hepatocytes and High-Resolution Mass Spectrometry
  The AAPS Journal, 2013
• New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products
  Forensic Toxicology, 2012
• Detection of urinary metabolites of AM‐2201 and UR‐144, two novel synthetic cannabinoids
  Drug Testing and Analysis, 2012
• Characterization ofIn VitroMetabolites ofCP47,497, a Synthetic Cannabinoid, in Human Liver Microsomes byLC‐MS/MS
  Journal of Forensic Sciences, 2012
• Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in ‘herbal mixtures’ using LC‐MS/MS techniques
  Journal of Mass Spectrometry, 2012
• Gas and liquid chromatography–mass spectrometry studies on the metabolism of the synthetic phenylacetylindole cannabimimetic JWH-250, the psychoactive component of smoking mixtures
  Journal of Chromatography B, 2011
• Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity
  PLOS ONE, 2011
• In vitro phase I metabolism of the synthetic cannabimimetic JWH-018
  Analytical and Bioanalytical Chemistry, 2010
• Acyl glucuronides: the good, the bad and the ugly
  Biopharmaceutics & Drug Disposition, 2010
• An Automated Liquid Chromatography-Mass Spectrometry Process to Determine Metabolic Stability Half-Life and Intrinsic Clearance of Drug Candidates by Substrate Depletion
  ASSAY and Drug Development Technologies, 2008